Examples of using Data presented by in English and their translations into French
{-}
-
Official
-
Colloquial
The busiest airports in Malaysia are measured according to data presented by Malaysia Airports Holdings Berhad.
Consequently, the early adoption of IFRS 8 had no material impact on segment data presented by Vivendi.
use comparable data presented by the U. K.
According to the historical data presented by Al-Ghazzi, the vast majority of the Aleppine Christians were Catholics until the 1920s.
Some countries reacted to the data presented by pointing out that it did not conform to their official reports.
In the view of the Panel, some of the data presented by Kuwait to support this claim are difficult to interpret.
The data presented by 107 companies indicated a reduction of 10.5 percent in air emissions,
The data presented by the panellists had been relevant to Member States' needs,
The backset measurement variability across labs fit between the estimates made from data presented by Japan and International Organization of Motor Vehicle Manufacturers OICA.
which is confirmed by official data presented by the competent institutions.
The data presented by one of the hospitals in the country indicated that 5 percent of maternal deaths could be directly attributed to malaria.
the basis of a report and accompanying statistical data presented by the representative of the Secretary-General.
draw nuggets of analysis even from the raw data presented by the Secretariat, especially if one has previous volumes at hand.
the busiest airports in Indonesia are measured according to data presented by the Airport Council International organization
The working group considered data presented by the Netherlands as well as data from the USA regarding calculated distances obtained by projectiles of specific weights and energy.
Based on data presented by IPP at our meeting on December 1, 2000,
The main purpose of an external audit is to protect the reliability of financial data presented by market participants
What was entirely unexpected was the interim data presented by Biomarin on its Phase I/II gene therapy trial of BMN 270 for hemophilia A with an AAV5 vector.
The Board reviewed the investments of the Fund on the basis of a report and accompanying statistical data presented by the representative of the Secretary-General for the investments of the Fund.
None of the data presented by the contractors have been evaluated by the secretariat, so no comments can be made regarding the scientific validity